Docetaxel

البلد: نيوزيلاندا

اللغة: الإنجليزية

المصدر: Medsafe (Medicines Safety Authority)

العنصر النشط:

Docetaxel trihydrate 100.71mg equivalent to anhydrous docetaxel 80 mg

متاح من:

REX Medical Ltd

INN (الاسم الدولي):

Docetaxel trihydrate 100.71 mg (equivalent to anhydrous docetaxel 80 mg)

جرعة:

80 mg/mL

الشكل الصيدلاني:

Concentrate for infusion

تركيب:

Active: Docetaxel trihydrate 100.71mg equivalent to anhydrous docetaxel 80 mg Excipient: Citric acid Polysorbate 80 Ethanol Water for injection

الوحدات في الحزمة:

Vial, glass, Diluent, 6 mL

الفئة:

Prescription

نوع الوصفة الطبية :

Prescription

المصنعة من قبل:

Cipla Ltd

الخصائص العلاجية:

Docetaxel is indicated for the treatment of patients with locally advanced or metastatic breast cancer in whom previous chemotherapy has failed. Docetaxel in combination with capecitabine is indicated for the treatment of patients with locally advanced or metastatic breast cancer after failure of prior anthracycline containing chemotherapy. Docetaxel in combination with trastuzumab is indicated for the treatment of patients with metastatic breast cancer whose tumours express HER2 and who previously have not received chemotherapy for metastatic disease.

ملخص المنتج:

Package - Contents - Shelf Life: Vial, glass, Diluent - 6 mL - 24 months from date of manufacture - Vial, glass, concentrate solution - 80 mg - 24 months from date of manufacture stored at 2° to 8°C (Refrigerate, do not freeze)

تاريخ الترخيص:

2006-06-23